Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits – Investor’s Business Daily

Celcuity just won FDA approval for its first drug, a treatment for metastatic breast cancer.

#stockmarket #breaking

Leave a Reply

WP Twitter Auto Publish Powered By : XYZScripts.com